Es gab 50 kürzliche Insider-Transaktionen für Achieve Life Sciences, Inc. (ACHV), darunter 31 Käufe und 12 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $10.24M und die gesamten Insider-Verkäufe auf RSU Award.
Bedeutende Insider mit kürzlicher Aktivität umfassen Oki Mark K, Stewart Richard Alistair, Wan Jerry. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — ACHV
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-01-28 |
Oki Mark K |
Chief Financial Officer |
RSU-Zuteilung |
180,000 |
$4.36 |
$784.8K |
180,000 |
| 2026-01-28 |
Stewart Richard Alistair |
Chief Executive Officer |
RSU-Zuteilung |
645,000 |
$4.36 |
$2.81M |
645,000 |
| 2026-01-28 |
Wan Jerry |
Principal Accounting Officer |
RSU-Zuteilung |
70,300 |
$4.36 |
$306.51K |
70,300 |
| 2026-01-28 |
Xinos Jaime |
Chief Commercial Officer |
RSU-Zuteilung |
180,000 |
$4.36 |
$784.8K |
180,000 |
| 2026-01-28 |
Donnelly Craig |
Chief Operations Officer |
RSU-Zuteilung |
180,000 |
$4.36 |
$784.8K |
180,000 |
| 2026-01-28 |
Rubinstein Mark Lawrence |
Chief Medical Officer |
RSU-Zuteilung |
180,000 |
$4.36 |
$784.8K |
180,000 |
| 2026-01-01 |
Rubinstein Mark Lawrence |
Chief Medical Officer |
Unbekannt |
50,000 |
$3.10 |
$155K |
- |
| 2025-12-04 |
Atkisson Erik |
Chief Legal Officer |
RSU-Zuteilung |
250,000 |
$4.78 |
$1.2M |
250,000 |
| 2025-10-20 |
Atkisson Erik |
Chief Legal Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-10-01 |
Donnelly Craig |
Chief Operations Officer |
RSU-Zuteilung |
50,000 |
$3.10 |
$155K |
50,000 |
| 2025-09-18 |
Oki Mark K |
Chief Financial Officer |
Optionsausübung (Verkauf) |
168,000 |
- |
- |
- |
| 2025-09-18 |
Stewart Richard Alistair |
Chief Executive Officer |
Optionsausübung (Verkauf) |
157,500 |
- |
- |
- |
| 2025-09-08 |
Donnelly Craig |
Chief Operations Officer |
Unbekannt |
25,000 |
$4.53 |
$113.25K |
- |
| 2025-09-04 |
Jacobs Cindy |
President & CMO |
Optionsausübung (Verkauf) |
84,000 |
- |
- |
- |
| 2025-09-04 |
King Thomas Braxton |
Director |
Optionsausübung (Verkauf) |
455,000 |
- |
- |
- |
| 2025-09-04 |
Oki Mark K |
Chief Financial Officer |
RSU-Rückgabe |
168,000 |
- |
- |
- |
| 2025-09-04 |
Stewart Richard Alistair |
Chieve Executive Officer |
RSU-Rückgabe |
157,500 |
- |
- |
- |
| 2025-09-04 |
Wan Jerry |
Principal Accounting Officer |
Optionsausübung (Verkauf) |
24,500 |
- |
- |
- |
| 2025-09-04 |
Xinos Jaime |
Chief Commercial Officer |
Optionsausübung (Verkauf) |
49,000 |
- |
- |
- |
| 2025-06-06 |
King Thomas Braxton |
Director |
RSU-Zuteilung |
31,500 |
$3.83 |
$120.65K |
31,500 |
| 2025-06-06 |
Martell Bridget A |
Director |
RSU-Zuteilung |
31,500 |
$3.83 |
$120.65K |
31,500 |
| 2025-06-06 |
Phelan Nancy R. |
Director |
RSU-Zuteilung |
31,500 |
$3.83 |
$120.65K |
31,500 |
| 2025-06-06 |
Sellig Thomas |
Director |
RSU-Zuteilung |
31,500 |
$3.83 |
$120.65K |
31,500 |
| 2025-06-06 |
Duty Stuart |
Director |
RSU-Zuteilung |
31,500 |
$3.83 |
$120.65K |
31,500 |
| 2025-06-06 |
Slaoui Kristen B. |
Director |
RSU-Zuteilung |
31,500 |
$3.83 |
$120.65K |
31,500 |
| 2025-03-17 |
Oki Mark K |
Chief Financial Officer |
Informierter Kauf |
10,000 |
$2.89 |
$28.89K |
10,000 |
| 2025-03-17 |
Stewart Richard Alistair |
Chieve Executive Officer |
Informierter Kauf |
10,000 |
$2.86 |
$28.6K |
60,876 |
| 2025-01-28 |
Jacobs Cindy |
President & CMO |
RSU-Zuteilung |
130,000 |
- |
- |
130,000 |
| 2025-01-28 |
Wan Jerry |
Principal Accounting Officer |
RSU-Zuteilung |
48,000 |
- |
- |
48,000 |
| 2025-01-28 |
Xinos Jaime |
Chief Commercial Officer |
RSU-Zuteilung |
100,000 |
- |
- |
100,000 |
| 2025-01-13 |
King Thomas Braxton |
Executive Chairman |
RSU-Zuteilung |
195,000 |
$3.32 |
$647.4K |
195,000 |
| 2025-01-13 |
Stewart Richard Alistair |
Chieve Executive Officer |
RSU-Zuteilung |
67,500 |
$3.32 |
$224.1K |
67,500 |
| 2025-01-13 |
Phelan Nancy R. |
Director |
RSU-Zuteilung |
47,250 |
$3.32 |
$156.87K |
47,250 |
| 2025-01-13 |
Xinos Jaime |
Chief Commercial Officer |
RSU-Zuteilung |
20,000 |
$3.32 |
$66.4K |
20,000 |
| 2025-01-13 |
Slaoui Kristen B. |
Director |
RSU-Zuteilung |
47,250 |
$3.32 |
$156.87K |
47,250 |
| 2025-01-06 |
Phelan Nancy R. |
Director |
Unbekannt |
- |
- |
- |
- |
| 2025-01-06 |
Slaoui Kristen B. |
Director |
Unbekannt |
- |
- |
- |
- |
| 2024-12-06 |
Oki Mark K |
Chief Financial Officer |
RSU-Zuteilung |
72,000 |
$4.52 |
$325.44K |
72,000 |
| 2024-12-06 |
Xinos Jaime |
Chief Commercial Officer |
RSU-Zuteilung |
30,000 |
$4.52 |
$135.6K |
30,000 |
| 2024-12-05 |
Oki Mark K |
Chief Financial Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-10-15 |
Xinos Jaime |
Chief Commercial Officer |
Unbekannt |
12,000 |
$10.36 |
$124.32K |
- |
| 2024-08-16 |
Jacobs Cindy |
President & CMO |
RSU-Zuteilung |
2,660 |
$3.67 |
$9.76K |
33,214 |
| 2024-08-16 |
Bencich John |
CEO |
RSU-Zuteilung |
5,000 |
$3.67 |
$18.35K |
100,636 |
| 2024-08-16 |
Wan Jerry |
Principal Accounting Officer |
RSU-Zuteilung |
2,857 |
$3.67 |
$10.49K |
12,664 |
| 2024-04-19 |
Jacobs Cindy |
President & CMO |
Optionsausübung (Verkauf) |
16,250 |
- |
- |
- |
| 2024-04-19 |
Bencich John |
CEO |
Optionsausübung (Verkauf) |
25,000 |
- |
- |
- |
| 2024-04-19 |
Stewart Richard Alistair |
Executive Chairman |
Optionsausübung (Verkauf) |
22,500 |
- |
- |
- |
| 2024-04-19 |
Wan Jerry |
Principal Accounting Officer |
Optionsausübung (Verkauf) |
5,625 |
- |
- |
- |
| 2024-03-04 |
Bencich John |
CEO |
Informierter Kauf |
10,000 |
$4.91 |
$49.06K |
10,000 |
| 2024-03-04 |
Stewart Richard Alistair |
Executive Chairman |
Informierter Kauf |
10,000 |
$4.91 |
$49.06K |
10,000 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
